0
Correspondence and Brief Communications |

Corticosteroids in Critically Ill Patients: A Long and Winding Road

Jorge Ibrain Figueira Salluh, MD, MSc; Anna Gabriela Fuks, MD, MSc
Arch Surg. 2006;141(9):945. doi:10.1001/archsurg.141.9.945-a.
Text Size: A A A
Published online

Extract

In a recent issue, Dr Britt et al1 reported an increased morbidity in critically ill patients receiving steroids. The immunosuppressive properties of corticosteroids as well as other hazardous adverse effects such as hyperglycemia and myopathy are well-described and definite causes of morbidity in the critically ill. However, although the morbidity burden associated with corticosteroids cannot be underestimated, we believe the study's results should be viewed with caution because it presents significant shortcomings. A major drawback is imposed by dissimilar indications and, consequently, dosages, type, and duration of steroid treatment for a heterogeneous population. In the past decade, several studies revealed that severe infections and the immune response to microorganisms are implicated in hypothalamic-pituitary-adrenal axis alterations, resulting in a status of relative adrenocortical insufficiency.2,3 Recent studies provide strong evidence that patients with severe sepsis4 or severe community-acquired pneumonia5 have high rates of relative adrenal failure and can have significant improvement in organ function and mortality when treated with a short course (7-10 days) of low-dose hydrocortisone.4,6

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com
brightcove.createExperiences();